Search Results

Filter
  • 1-10 of  414 results for ""Tissue Plasminogen Activator""
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Interactions between iodinated contrast media and tissue plasminogen activator: In vitro comparison study.

  • Authors : Vörös E; Department of Radiology, University of Pecs Medical School, Pecs, Hungary.; Deres L

Subjects: Computed Tomography Angiography/Computed Tomography Angiography/Computed Tomography Angiography/*methods ; Contrast Media/Contrast Media/Contrast Media/*pharmacology ; Thrombolytic Therapy/Thrombolytic Therapy/Thrombolytic Therapy/*methods

  • Source: Clinical hemorheology and microcirculation [Clin Hemorheol Microcirc] 2017; Vol. 66 (2), pp. 167-174.Publisher: Ios Press Country of Publication: Netherlands NLM ID: 9709206 Publication Model: Print Cited Medium: Internet

Record details

×
Academic Journal

Comparative study on the efficacy and safety of alteplase and urokinase in the treatment of acute cerebral infarction.

  • Authors : Bao H; Department of Neurology, Hulun Buir People's Hospital, Hulun Buir, Inner Mongolia, China.; Gao HR

Subjects: Stroke*/Stroke*/Stroke*/drug therapy ; Tissue Plasminogen Activator*/Tissue Plasminogen Activator*/Tissue Plasminogen Activator*/therapeutic use; Cerebral Infarction/Cerebral Infarction/Cerebral Infarction/drug therapy

  • Source: Technology and health care : official journal of the European Society for Engineering and Medicine [Technol Health Care] 2021; Vol. 29 (1), pp. 85-90.Publisher: IOS Press Country of Publication: Netherlands NLM ID: 9314590 Publication Model: Print Cited Medium: Internet

Record details

×
Academic Journal

Tissue plasminogen activator (rt-PA) in acute ischemic stroke: Outcomes associated with ambulation.

  • Authors : Lawson TR; University of South Carolina School of Medicine, SC, USA.; Brown IE

Subjects: Brain Ischemia/Brain Ischemia/Brain Ischemia/*drug therapy ; Fibrinolytic Agents/Fibrinolytic Agents/Fibrinolytic Agents/*therapeutic use ; Motor Activity/Motor Activity/Motor Activity/*drug effects

  • Source: Restorative neurology and neuroscience [Restor Neurol Neurosci] 2015; Vol. 33 (3), pp. 301-8.Publisher: IOS Press Country of Publication: Netherlands NLM ID: 9005499 Publication Model: Print Cited Medium: Internet

Record details

×
Academic Journal

Examination of the protective effects of heparin and recombinant tissue plasminogen activator (rtPA) in compromised adipocutaneous free flaps in the rat model using intravital video microscopy.

  • Authors : Wallmichrath J; Hand Surgery, Plastic Surgery and Aesthetic Surgery, University Hospital of the Ludwig-Maximilians-University, Campus Grosshadern, Munich, Germany.; Birk C

Subjects: Free Tissue Flaps/Free Tissue Flaps/Free Tissue Flaps/*blood supply ; Heparin/Heparin/Heparin/*therapeutic use ; Microscopy, Video/Microscopy, Video/Microscopy, Video/*methods

  • Source: Clinical hemorheology and microcirculation [Clin Hemorheol Microcirc] 2015; Vol. 59 (3), pp. 185-95.Publisher: Ios Press Country of Publication: Netherlands NLM ID: 9709206 Publication Model: Print Cited Medium: Internet

Record details

×
Academic Journal

Changes in coagulation and tissue plasminogen activator after the treatment of cerebral infarction with lumbrokinase.

  • Authors : Jin L; Department of Neurology, Zhongshan Hospital, Shanghai Medical University, China.; Jin H

Subjects: Thrombolytic Therapy*; Blood Coagulation/Blood Coagulation/Blood Coagulation/*drug effects ; Cerebral Infarction/Cerebral Infarction/Cerebral Infarction/*drug therapy

  • Source: Clinical hemorheology and microcirculation [Clin Hemorheol Microcirc] 2000; Vol. 23 (2-4), pp. 213-8.Publisher: Ios Press Country of Publication: Netherlands NLM ID: 9709206 Publication Model: Print Cited Medium: Print

Record details

×
Academic Journal

Analysis of factors influencing the blood levels and activities of tissue-type plasminogen activator (t-PA).

  • Authors : Wei R; Institute of Basic Medical Science, Taishan Medical College, Taian, Shandong 271000, China.; Han JJ

Subjects: Hemorheology*; Blood Glucose/Blood Glucose/Blood Glucose/*analysis ; Lipids/Lipids/Lipids/*blood

  • Source: Clinical hemorheology and microcirculation [Clin Hemorheol Microcirc] 2003; Vol. 29 (3-4), pp. 351-6.Publisher: Ios Press Country of Publication: Netherlands NLM ID: 9709206 Publication Model: Print Cited Medium: Print

Record details

×
Academic Journal

Association between Plasma Levels of PAI-1, tPA/PAI-1 Molar Ratio, and Mild Cognitive Impairment in Chinese Patients with Type 2 Diabetes Mellitus.

  • Authors : Wang J; Department of Endocrinology, The Affiliated ZhongDa Hospital of Southeast University, Nanjing, PR China.; Medical School of Southeast University, Nanjing, PR China.

Subjects: Cognitive Dysfunction/Cognitive Dysfunction/Cognitive Dysfunction/*blood ; Diabetes Mellitus, Type 2/Diabetes Mellitus, Type 2/Diabetes Mellitus, Type 2/*blood ; Diabetes Mellitus, Type 2/Diabetes Mellitus, Type 2/Diabetes Mellitus, Type 2/*psychology

  • Source: Journal of Alzheimer's disease : JAD [J Alzheimers Dis] 2018; Vol. 63 (2), pp. 835-845.Publisher: IOS Press Country of Publication: Netherlands NLM ID: 9814863 Publication Model: Print Cited Medium: Internet

Record details

×
Academic Journal

Using antifibrinolytics in the peripartum period - concern for a hypercoagulable effect?

  • Authors : Ahmadzia HK; Department of Obstetrics and Gynecology, Division of Maternal-Fetal Medicine, Duke University, Durham, NC, USA.; Lockhart EL

Subjects: Aminocaproic Acid/Aminocaproic Acid/Aminocaproic Acid/*pharmacology ; Antifibrinolytic Agents/Antifibrinolytic Agents/Antifibrinolytic Agents/*pharmacology ; Blood Coagulation/Blood Coagulation/Blood Coagulation/*drug effects

  • Source: Journal of neonatal-perinatal medicine [J Neonatal Perinatal Med] 2017; Vol. 10 (1), pp. 1-7.Publisher: IOS Press Country of Publication: Netherlands NLM ID: 101468335 Publication Model: Print Cited Medium:

Record details

×
Academic Journal

Tissue plasminogen activator and inhibitors of fibrinolysis in malignant melanoma.

  • Authors : Kwaan HC; Department of Medicine, Northwestern University Medical School, Chicago, Ill.; Radosevich JA

Subjects: Fibrinolysis/Fibrinolysis/Fibrinolysis/*drug effects ; Melanoma/Melanoma/Melanoma/*enzymology ; Tissue Plasminogen Activator/Tissue Plasminogen Activator/Tissue Plasminogen Activator/*analysis

  • Source: Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine [Tumour Biol] 1988; Vol. 9 (6), pp. 301-6.Publisher: IOS Press Country of Publication: Netherlands NLM ID: 8409922 Publication Model: Print Cited Medium: Print

Record details

×
Academic Journal

Interdisciplinary rehabilitation outcomes following thrombolysis for acute ischaemic stroke: a case series.

  • Authors : Finch E; Division of Speech Pathology, School of Health and Rehabilitation Sciences, The University of Queensland, QLD, Australia Speech Pathology Department, Princess Alexandra Hospital, QLD, Australia Centre for Functioning and Health Research, Queensland Health, QLD, Australia.; Fleming J

Subjects: Stroke Rehabilitation*; Brain Ischemia/Brain Ischemia/Brain Ischemia/*drug therapy ; Brain Ischemia/Brain Ischemia/Brain Ischemia/*rehabilitation

  • Source: NeuroRehabilitation [NeuroRehabilitation] 2014; Vol. 35 (1), pp. 9-16.Publisher: IOS Press Country of Publication: Netherlands NLM ID: 9113791 Publication Model: Print Cited Medium: Internet

Record details

×
  • 1-10 of  414 results for ""Tissue Plasminogen Activator""